Medigene AG
Ad hoc-Service: MediGene AG English
Ad hoc-Mitteilung verarbeitet und übermittelt durch die DGAP.
Für den Inhalt der Mitteilung ist der Emittent verantwortlich.
——————————————————————————
MediGene AG Acquires NeuroVir Therapeutics, Inc.
MediGene Aktiengesellschaft Gesellschaft für molekularbiologische Kardiologie
und Onkologie (“MediGene”) and NeuroVir Therapeutics, Inc. (“NeuroVir”) have
signed an agreement under which NeuroVir would become a wholly-owned subsidiary
of MediGene. Consummation of the transaction is subject to a series of
conditions, including the vote of NeuroVir shareholders, regulatory approvals
and an independent examination of the agreed economic exchange. NeuroVir, a
privately-owned Delaware corporation with its principal place of business in San
Diego. California/USA, is a development-stage biotech company with herpes
simplex virus technologies for the potential treatment of tumors and for gene
delivery. It has two product candidates in clinical trials. MediGene has agreed
to issue with an exclusion of pre-emptive rights of existing shareholders
between 996,631 and 1,009,999 new MediGene shares to NeuroVir shareholders
against a capital contribution of all outstanding shares, options and warrants
of NeuroVir.
This ad hoc news release contains forward-looking statements that involve risks
and uncertainties. The forward-looking statements contained herein represent the
judgement of MediGene and NeuroVir as of the date of this release. These forward
looking statements are not guarantees for future performance, and the forward-
looking events discussed in this press release may not occur. MediGene and
NeuroVir disclaim any intent or obligation to update any of these forward-
looking statements.
For further information please contact:
MediGene AG
Angelika Heinz, VP, Head of Finance Phone: ++49 – 89 – 89 56 32-0
Christine Bohner, Public Relations Officer Phone: ++49 – 89 – 89 56 32-16
email: investor@medigene.de
URL: www.medigene.de
Ende der Mitteilung
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found